The CCS Guidelines Committee is seeking member input to determine guideline and position statement topics for development in 2019 – 2020. You must be a CCS member to submit a topic and work on the statement cannot already be initiated.
Thank you to our Canadian Cardiovascular Society (CCS) members who continue to demonstrate their commitment to their profession, career and patients by renewing their membership. As a CCS member, you understand the value of belonging to the Society and how your support contributes to a strong, relevant and influential cardiovascular sector in Canada. You can renew quickly and easily at MY.CCS.ca.
In this position statement the CCS and the Canadian Heart Rhythm Society (CHRS) address the lack of a Canadian position on cardiovascular screening of competitive athletes by creating appropriate, evidence-based recommendations for Canadian sporting organizations and institutions. The recommendations focus on the role of routine ECG screening for the prevention of Sudden Cardiac Death and outline the elements of cardiovascular screening such as the history, physical examination, and the 12-lead ECG. Additionally, the importance of shared decision making is encouraged when cardiac conditions are diagnosed, and policies and procedures are described for the management of emergencies in sport settings. Look out for the published article in the January issue of the Canadian Journal of Cardiology (CJC).
Read the full article.
Familial Hypercholesterolemia (FH) is the most common monogenetic disorder affecting 1 in 250 individuals. Patients with FH have a significantly higher risk for cardiovascular events than the average person; however, FH is under-diagnosed and under-treated worldwide.
The 2018 Update provides new evidence on the diagnosis and management of FH, and addresses the need for prompt recognition, treatment and screening. Using a new Canadian definition for FH, updated recommendations provide an improved understanding of treatment gaps for FH in Canada and suggest tools and calculators for screening to aid clinicians in the diagnosis and treatment of FH.
By promoting knowledge translation and availability of treatment resources, the statement also aims to raise awareness of FH nationally and mobilize patient support for this under-recognized, but important medical condition.
The published article is available in the December issue of the Canadian Journal of Cardiology.
Read the full article.
Dr. Jason Andrade returns for the latest CJC podcast
Follow @CJC_JCC on Twitter for the latest articles in the field of cardiology.